Vitamin D analogs: mechanism of action and therapeutic applications

S Nagpal1, J Lu, M F Boehm

  • 1Gene Regulation, Bone and Inflammation Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis IN-46285, USA. nagpal_sunil@lilly.com

Current Medicinal Chemistry
|September 20, 2001
PubMed

Insights

Vitamin D analogs, known as VDR ligands, show promise for treating various diseases beyond bone health, including inflammation and cancer. However, their use is limited by toxicity, leading to the development of safer, more specific compounds.

Area of Science:

  • Endocrinology
  • Dermatology
  • Oncology
  • Immunology

Background:

  • Vitamin D receptor (VDR) ligands, like 1 alpha,25-dihydroxyvitamin D3, influence numerous cellular processes beyond calcium homeostasis.
  • These noncalcemic actions include anti-proliferative, prodifferentiative, and immunomodulatory effects, with VDR ligands already approved for psoriasis treatment.

Purpose of the Study:

  • To explore the broad therapeutic potential of VDR ligands in diverse diseases.
  • To address the toxicity limitations of current VDR ligands and highlight the development of novel analogs.

Main Methods:

  • Review of existing literature on VDR ligand actions and clinical applications.
  • Analysis of preclinical and clinical trial data for various VDR ligand-responsive conditions.
  • Examination of newly synthesized VDR analogs with improved specificity and reduced calcemic potential.

Main Results:

  • VDR ligands demonstrate therapeutic potential in inflammatory diseases, dermatological conditions, osteoporosis, cancers, and autoimmune disorders.
  • Preclinical studies show preventive and therapeutic anabolic effects in osteoporosis models.
  • Despite toxicity concerns (hypercalcemia), novel VDR ligands with reduced calcemic effects are being developed.

Conclusions:

  • VDR ligands offer a wide range of potential clinical applications due to their diverse biological activities.
  • Development of novel, specific VDR analogs is crucial for overcoming toxicity and expanding therapeutic use.
  • Further research into VDR mechanisms and analog development promises improved treatments for various diseases.

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...